Bakterielle Fehlbesiedlung des Dünndarms

J. M. Stein; A. R. Schneider

doi:10.1055/s-2007-963045

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2007; 45(7): 620-628
DOI: 10.1055/s-2007-963045

Übersicht

Bakterielle Fehlbesiedlung des Dünndarms

Bacterial Overgrowth SyndromeJ. M. Stein¹ , A. R. Schneider¹

¹Medizinische Klinik I-ZAFES (Direktor: Prof. Dr. S. Zeuzem), J. W. Goethe-Universität Frankfurt

Abstract

Zusammenfassung

Die bakterielle Fehlbesiedlung des Dünndarms ist durch eine pathologisch erhöhte Anzahl luminaler Bakterien im Bereich des Dünndarms bedingt. Prädisponierend sind vornehmlich Veränderungen der intestinalen Motilität, der physiologischen Darmanatomie durch chirurgische Eingriffe und eine verminderte gastrale Sekretionsleistung. Die bakterielle intestinale Fehlbesiedlung steht im Zusammenhang mit einer Vielzahl von Symptomen, die von oligosymptomatischen Verläufen bis zu Anämie, Steatorrhö oder einer Proteinverlust-Enteropathie reichen können. Therapeutisch steht - soweit möglich - die Beseitigung der ursächlichen Erkrankung im Vordergrund. Gleichzeitig erfolgen die antibiotische Eradikation der Keime und die Substitution nutritiver Mangelerscheinungen.

Abstract

Small bowel bacterial overgrowth is a syndrome caused by an abnormal number of bacteria in the upper part of the small bowel and associated with a complex array of clinical symptoms, i. e., chronic diarrhoea, steatorrhoea, macrocytic anaemia, weight loss, and less commonly, protein-losing enteropathy. The most common underlying factors are small intestinal stagnation or dysmotility, intestinal obstruction, blind or afferent loops, and decreased gastric secretion. The treatment usually consists in the eradication of bacterial overgrowth with repeated courses of antimicrobials, correction of associated nutritional deficiencies and, when possible, correction of the underlying predisposing conditions.

Schlüsselwörter

bakterielle Fehlbesiedlung - Malassimilation - Colon irritabile

Key words

bacterial overgrowth - malassimilation - irritable colon

Full Text

References

Literatur

1 Abrahamsson H. Gastrointestinal motility in patients with the irritable bowel syndrome. Scand J Gastroenterol Suppl. 1987; 130 21-26
2 Almeida J, Galhenage S, Yu J. et al . Gut flora and bacterial translocation in chronic liver disease. World J Gastroenterol. 2006; 12 1493-1502
3 Attar A, Flourie B, Rambaud J C. et al . Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: A crossover, randomized trial. Gastroenterology. 1999; 117 794-799
4 Bardham F K, Gyr K, Beglinger C. et al . Diagnosis of bacterial overgrowth after culturing small bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol. 1992; 27 253-258
5 Bauer T M, Steinbruckner B, Brinkmann F E. et al . Small intestinal bacterial overgrowth and bacterial translocation in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol. 2001; 97 2364-2370
6 Biancone L, Vernia P, Agostini D. et al . Effect of rifaximin on intestinal bacterial overgrowth in Crohn’s disease as assessed by the H2-Glucose Breath Test. Curr Med Res Opin. 2000; 16 14-20
7 Blaut M. Ökologie des Darms. Caspary WF, Kist M, Stein J. Infektiologie des Gastrointestinaltraktes Springer Verlag Berlin, Heidelberg, New York; 2006: 31-44
8 Bjorneklett A, Fausa O, Midtvedt T. Small bowel bacterial overgrowth in the postgastrectomy syndrome. Scand J Gastroenterol. 1983; 18 277-287
9 Bjorneklett A, Fausa O, Midtvedt T. Bacterial overgrowth in jejunal and ileal disease. Scand J Gastroenterol. 1983; 18 289-298
10 Bouhnik Y, Alain S, Attar A. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol. 1999; 94 1327-1331
11 Brandt L J, Bernstein L H, Wagle A. Production of vitamin B12 analogues in patients with small-bowel bacterial overgrowth. Ann Intern Med. 1977; 87 546-551
12 Brummer R J, Armbrecht U, Bosaeus I. et al . The hydrogen (H2) breath test. Sampling methods and the influence of dietary fibre on fasting level. Scand J Gastroenterol. 1985; 20 1007-1013
13 Caspary W F, Reimold W V. Klinische Bedeutung des 14C-Glykocholat-Atemtests in der gastroenterologischen Diagnostik bei Erkrankungen mit gesteigerter Dekonjugation von Gallensäuren. Dtsch Med Wschr. 1976; 101 353-360
14 Castiglione F, Rispo A, Di Girolamo E. et al . Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease. Aliment Pharmacol Ther. 2003; 18 1107-1112
15 Chang C S, Chen G H, Lien H C. et al . Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 1998; 28 1187-1190
16 Chang J, Defilippi C, Defilippi C. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 1998; 28 1187-1190
17 Corazza G R, Menozzi M G, Strocchi A. et al . The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990; 98 302-309
18 Corazza G R, Di Stefano M, Scarpignato C. Treatment of functional bowel disorders: is there room for antibiotics?. Digestion. 2006; 73 (Suppl 1) 38-46
19 Cuoco L, Montalto M, Jorizzo R A. et al . Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. Hepatogastroenterology. 2002; 49 1582-1586
20 Cuoco L, Salvagnini M. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin. Minerva Gastroenterol Dietol. 2006; 52 89-95
21 Dear K L, Elia M, Hunter J O. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?. Dig Dis Sci. 2005; 50 758-766
22 Dellert S F, Nowicki M J, Farrell M K. et al . The 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children. J Pediatr Gastroenterol Nutr. 1997; 25 153-158
23 Dibaise J K, Young R J, Vanderhoof J A. Enteric microbial flora, bacterial overgrowth, and short-bowel sindrome. Clin Gastroenterol Hepatol. 2006; 4 11-20
24 Di Stefano M, Malservisi S, Veneto G. et al . Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2000; 14 551-556
25 Di Stefano M, Miceli E, Missanelli A. et al . Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther. 2005; 21 985-992
26 Draganov P, Toskes P. Is the prevalence of small bowel bacterial overgrowth in patients with irritable bowel syndrome increased? The question remains unanswered. Dig Dis Sci. 2005; 50 1461
27 Elphick D A, Chew T S, Higham S E. Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier?. Gerontology. 2005; 51 396-401
28 Falk P G, Hooper L V, Midvedt T. et al . Creating and maintaining the gastrointestinal ecosystem: what we know and need to knoe from gnotobiology. Microbiol Mol Biol Rev. 1998; 62 1157-1170
29 Fried M, Siegrist H, Frei R. et al . Duodenal bacterial overgowth during treatment in outpatients with omeprazole. Gut. 1994; 35 23-26
30 Ghoshal U, Ghoshal U C, Ranjan P. et al . Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics. BMC Gastroenterol. 2003; 3 9
31 Gianella R A, Rout W R, Toskes P P. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology. 1974; 80 965-974
32 Gorbach S L, Nahas L, Lerner P I. et al . Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology. 1967; 53 845-855
33 Gregg C R, Toskes P P. Enteric bacterial flora and small bowel bacterial overgrowth syndrome. Feldman M, Scharschmidt BF, Sleisenger MH Gastrointestinal and liver disease Philadelphia; W.B. Saunders 2002: 1783-1793
34 Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2005; 17 27-31
35 Riordan S M, McIver C J, Wakefield D. et al . Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol. 1997; 92 47-51
36 Gunnarsdottir S A, Sadik R, Shev S. et al . Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and potal hypertension. Am J Gastroenterol. 2003; 98 1362-1370
37 Hansel S, Lyden E, Gilroy R. et al . Prevalence and risk factors of small intestinal bacterial overgrowth in short bowel syndrome. Gastroenterology. 2005; 128 A679
38 Hoverstad T, Bjoneklet A, Fausa O. et al . Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome. Scand J Gastroenterol. 1985; 20 492-499
39 Husebye E, Skar V, Hoverstad T. et al . Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut. 1992; 33 1331-1337
40 Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med. 1995; 237 419-427
41 Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy. 2005; 51 (Suppl 1) 1-22
42 Keller J, Franke A, Storr M. et al . Klinisch relevante Atemtests in der gastroenterogischen Diagnostik - Empfehlungen der Deutschen Gesellschaft für Neurogastroenterologie und Motilität sowie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen. Z Gastroenterol. 2005; 43 1071-1090
43 Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1998; 95 982-987
44 King C E, Toskes P. Protein-losing enteropathy in the human and experimental rat blind loop syndrome. Gastroenterology. 1981; 80 504-511
45 King T S, Elia M, Hunter J O. Abnormal colonic fermentation in irritable bowel syndrome. Lancet. 1998; 352 1187-1189
46 King C E, Toskes P P, Guilarte T R. et al . Comparison of the one-gram D-[¹⁴C]xylose breath test to the [¹⁴C]bile acid breath test in patients with small intestinal bacterial overgrowth. Dig Dis Sci. 1980; 25 53-58
47 Kohler H, McCormick B A, Walker B A. Bacterial-enterocyte crosstalk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr. 2003; 36 175-185
48 Lauritano E C, Gabrielli M, Lupascu A. et al . Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2005; 22 31-35
49 Lewis S J, Franco S, Young G. et al . Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996; 10 557-561
50 Li E. Bacterial overgrowth. Yamada T, Alpers DH, Laine L, Owyang C, Powell DW ( Textbook of Gastroenterology Philadelphia; Lippincott Williams & Wilkins 1999: 1697-1703
51 Lichtman S N, Keku J, Schwab J H. et al . Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology. 1991; 100 512-519
52 Lin H C. Small intestinal bacterial overgrowth: A framework for understanding irritable bowel disease. JAMA. 2004; 292 852-858
53 Lupascu A, Gabrielli M, Lauritano E C. et al . Hydrogene glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther. 2005; 22 1157-1160
54 Mackie R I, Sghir A, Gaskins H R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr. 1999; 69 1035S-1045S
55 Madrid A M, Hurtado C, Venegas M. et al . Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol. 2001; 96 1251-1255
56 McEvoy A, Dutton J, James O FW. Bacterial contamination of the small intestine is an important cause of occult malabsorption in the elderly. BMJ. 1983; 287 789-793
57 Milberg P, Eckardt L, Bruns H J. et al . Divergent Proarrhythmic Potential of Macrolide Antibiotics Despite Similar QT Prolongation: Fast Phase 3 Repolarization Prevents Early Afterdepolarizations and Torsade de Pointes. J Pharmacol Exp Ther. 2002; 303 218-225
58 Morencos F C, de las Heras Castano G, Martin Ramos L. et al . Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci. 1995; 40 1252-1256
59 Morenos F C, De Las Heras Castano G, Meal R. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci. 1995; 40 1252-1256
60 Mowat C, Williams C, Gillen D. et al . Helicobacter pylori status and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology. 2000; 119 339-347
61 Nayak A K, Karnad D R, Abraham P. et al . Metronidazole relieves symptoms in irritable bowel syndrome: the confusion with so-called „chronic amebiasis”. Indian J Gastroenterol. 1997; 16 137-139
62 Nieuwenhuijs V B, Verheem A, Duijvebode-Beumer van H. et al . The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg. 1998; 228 188-193
63 O’Keefe S J. Bacterial overgrowth and liver complications in short bowel intestinal failure patients. Gastroenterology. 2006; 130 (Suppl 1) S67-S69
64 Pardo A, Bartoli R, Lorenzo-Zuniga V. et al . Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology. 2000; 31 858-863
65 Pelosini I, Scarpignato C. Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tract. Chemotherapy. 2005; 51 122-130
66 Pimentel M, Chow E J, Lin H C. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000; 95 3503-3506
67 Pimentel M, Chow E J, Lin H C. Normalization of lactulose breath testing correlated with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003; 98 412-419
68 Pimentel M, Soffer E, Chow E J. et al . Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci. 2002; 47 2639-2643
69 Pimentel M, Park S, Mirocha J. et al . The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. 2006; 145 557-563
70 Pimentel M, Chatterjee S, Chow E J. et al . Neomycin Improves Constipation-Predominant Irritable Bowel Syndrome in a Fashion That Is Dependent on the Presence of Methane Gas: Subanalysis of a Double-Blind Randomized Controlled Study. Dig Dis Sci. 2006; 51 1297-301
71 Posserud I, Stotzer P O, Bjornsson E. et al . Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2006; [Epub ahead of print];
72 Riordan S M, McIver C J, Walker B M. et al . The lactulose breath tests and small intestinal overgrowth. Am J Gastroenterol. 1996; 91 1795-1799
73 Riordan S M, McIver C J, Wakefield D. et al . Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol. 1997; 92 47-51
74 Riordan S M, McIver C J, Wakefield D. et al . Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am J Gastroenterol. 2001; 96 494-500
75 Romagnuolo J, Schiller D, Bailey R J. Using breath tests wisely used in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpreatation. Am J Gastroenterol. 2002; 97 1113-1116
76 Rumessen J J, Gudmand-Hoyer E, Bachmann E. et al . Diagnosis of bacterial overgrowth of the small intestine. Comparison of the 14C-D-xylose breath test and jejunal cultures in 60 patients. Scand J Gastroenterol. 1985; 20 1267-1275
77 Sadik R, Abrahamson H, Bjornsson E. et al . Etiology of portal hypertension may influence gastrointestinal transit. Scand J Gastroenterol. 2003; 38 1039-1044
78 Saltzman J R, Kowdley K V, Pedrosa M C. et al . Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology. 1994; 106 615-623
79 Sanduleanu S, Jonkers D, De Bruine A. et al . Non-helicobacter pylori bacterial flora during acid-suppressive therapy: differential fidings in gastric juice and gastric mucosa. Aliment Pharmacol Ther. 2001; 15 379-388
80 Schmidt T, Pfeiffer A, Kaess H. Abnormal intestinal motility in irritable bowel syndrome. Gastroenterology. 1996; 111 1400-1401
81 Scott L D, Cahall D L. Influence of the interdigestive myoelectric complex on enteric flora in the rat. Gastroenterology. 1982; 82 737-745
82 Sharma B K, Santana I A, Wood E C. et al . Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J. 1984; 289 717-719
83 Sherman P, Wesley A, Forstner G G. Sequential disacchridase loss in rat intestinal blind loops: impact of malnutrition. Am J Physiol. 1985; 248 G626-G632
84 Shindo K, Machida M, Koide K. et al . Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology. 1998; 45 1643-1650
85 Simren M, Stotzer P O. Use and abuse of hydrogen breath tests. Gut. 2006; 55 (3) 297-303
86 Strid H, Simren M, Stotzer P O. et al . Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth. Digestion. 2003; 67 (3) 129-137
87 Solomons N W, Schoeller D A, Wagonfeld J B. et al . Application of a stable isotope (13C)-labeled glycocholate breath test to the diagnosis of bacterial overgrowth. J Lab Clin Med. 1977; 90 431-439
88 Soudah H C, Hasler W I, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. New Engl J Med. 1991; 325 1461-1467
89 Stockbruegger R W, Cotton P B. et al . Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand J Gastroenterol. 1984; 19 355-364
90 Stotzer P O, Blomberg L, Conway P L. et al . Probiotic treatment of small bacterial overgrowth by Lactobacillus fermentus KLD. Scand J Infect Dis. 1996; 28 615
91 Tabaqchali S, Hatzioannou J, Booth C C. Bile-salt deconjugation and steatorrhoea in patients with the stagnant-loop syndrome. Lancet. 1968; 2 (7558) 12-16
92 Theisen J, Nehra D, Citron D. et al . Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg. 2000; 4 50-54
93 Thorens J, Froehlich F, Schwizer W. et al . Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996; 39 54-59
94 Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin. 1999; 15 47-52
95 Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten with-drawal. Am J Gastroenterol. 2003; 98 839-843
96 Felius I D, Akkermans L M, Bosscha van K. et al . Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil. 2003; 15 267-276
97 Vanderhoof J A, Young R J. Probiotic therapy in children with short bowel syndrome and bacterial overgrowth (abstract). Gastroenterology. 1997; 112 A916
98 Vanderhoof J A, Young R J, Murray N. et al . Treatment strategies for small bowel bacterial overgrowth. J Pediatr Gastroenterol Nutr. 1998; 27 155-160
99 Verdu E F, Fraser R, Armstrong D. et al . Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers. Scand J Gastroenterol. 1994; 29 1065-1069
100 Welkos S L, Toskes P P, Baer H. et al . Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome. Gastroenterology. 1981; 80 313-320
101 Wigg A J, Roberts-Thomson I C, Dymock R B. et al . The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut. 2001; 48 206-211
102 Williams C, McColl K EL. Proton pump inhibitors and bacterial overgrowth. Aliment Pharmacol Ther. 2005; 23 3-10
103 Yang C Y, Chang C S, Chen G H. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath test. Scand J Gastroenterol. 1998; 33 867-871

Prof. Jürgen M. Stein

Med. Klinik I-ZAFES, Universität Frankfurt

Theodor-Stern-Kai 7

60590 Frankfurt

Phone: ++49/69/63 01 59 17

Fax: ++49/69/6 30 18 31 12

Email: j.stein@em.uni-frankfurt.de